Skip to main content
. 2017 May 15;50(6):e5797. doi: 10.1590/1414-431X20175797

Table 3. Antifungal susceptibility patterns of Candida species to different antifungal drugs.

Antifungal Species (n=130)
C. albicans (n=109) C. glabrata (n=11) C. tropicalis (n=8) C. dubliniensis (n=2) P
Fluconazole 0.277
S 102 (93.6%) 9 (81.8%) 6 (75%) 2 (100%)
I 2 (1.8%)
R 5 (4.6%) 2 (18.2%) 2 (25%)
Voriconazole 0.061
S 105 (96.3%) 9 (81.8%) 6 (75%) 2 (100%)
I 1 (0.9%)
R 3 (2.8%) 2 (18.2%) 2 (25%)
Caspofungin 0.065
S 105 (96.3%) 9 (81.8%) 6 (75%) 2 (100%)
R 4 (3.7%) 2 (18.2%) 2 (25%)
Micafungin 0.068
S 105 (96.3%) 9 (81.8%) 6 (75%) 2 (100%)
R 4 (3.7%) 2 (18.2%) 2 (25%)
Amphotericin B 0.068
S 105 (96.3%) 9 (81.8%) 6 (75%) 2 (100%)
R 4 (3.7%) 2 (18.2%) 2 (25%)
Flucytosine 0.0934
S 102 (93.6%) 10 (90.9%) 7 (87.5%) 2 (100%)
I 2 (1.8%)
R 5 (4.6%) 1 (9.1%) 1 (12.5%)

S: susceptible; I: intermediate; R: resistant. P<0.05 (chi-square test).